Skip to main content

Publisher: Bentham Science Publishers

Volume 12, Number 15, August 2012

Articles

Free Content Editorial [Hot Topic: A New Era of Gene Therapy]
pp. 1593-1593(1)
Authors: Suzuki, Jun-ichi; Morishita, Ryuichi

Favourites:
ADD
Favourites:
ADD

Modification of Decoy Oligodeoxynucleotides to Achieve the Stability and Therapeutic Efficacy
pp. 1603-1607(5)
Authors: Kiomy Osako, Mariana; Nakagami, Hironori; Morishita, Ryuichi

Favourites:
ADD

Applications of Nucleic Acid Drugs for Organ Transplantation
pp. 1608-1612(5)
Authors: Suzuki, Jun-ichi; Isobe, Mitsuaki; Morishita, Ryuichi; Nagai, Ryozo

Favourites:
ADD

Nucleic Acid Drugs for Preventing Restenosis after Coronary Revascularization
pp. 1613-1620(8)
Authors: Miyake, Takashi; Nakagami, Hironori; Morishita, Ryuichi

Favourites:
ADD

Development of Nucleic Acid Drugs for Neurological Disorders
pp. 1621-1629(9)
Authors: Shimamura, Munehisa; Sato, Naoyuki; Nakagami, Hironori; Taniyama, Yoshiaki; Morishita, Ryuichi

Favourites:
ADD

Therapeutic Option of Plasmid-DNA Based Gene Transfer
pp. 1630-1637(8)
Authors: Taniyama, Yoshiaki; Azuma, Junya; Kunugiza, Yasuo; Iekushi, Kazuma; Rakugi, Hiromi; Morishita, Ryuichi

Favourites:
ADD

Can Targeted Therapy be Successful without Metronomic Scheduling ?
pp. 1639-1642(4)
Authors: Andre, Nicolas; Pasquier, Eddy; Kamen, Barton

Favourites:
ADD

100% Human Monoclonal Antibodies in Oncology: Hype or Breakthrough?
pp. 1643-1648(6)
Authors: Benay, Stephan; Fanciullino, Raphaelle; Mercier, Cedric; Iliadis, Athanassios; Ciccolini, Joseph; Lacarelle, Bruno

Favourites:
ADD

Polymorphisms to Predict Outcome to the Tyrosine Kinase Inhibitors Gefitinib, Erlotinib, Sorafenib and Sunitinib
pp. 1649-1659(11)
Authors: Erdem, Lale; Giovannetti, Elisa; G Leon, Leticia; Honeywell, Richard; J. Peters, Godefridus

Favourites:
ADD

A New Model for Determining the MTD During Phase-I Trials in Pediatric Oncology
pp. 1660-1664(5)
Authors: Faivre, C.; Barbolosi, D.; Iliadis, A.

Favourites:
ADD

Optimize Administration Protocol of Capecitabine Plus Docetaxel Combination in Metastatic Breast Cancer Patients
pp. 1665-1668(4)
Authors: Frances, Nicolas; Woloch, Christian; Marouani, Hafedh; Mercier, Cedric; Iliadis, Athanassios

Favourites:
ADD

Progress in Strategies for Dosage Regimen Individualization
pp. 1669-1677(9)
Authors: Marouani, Hafedh; Woloch, Christian; Benay, Stephan; Frances, Nicolas; Iliadis, Athanassios

Favourites:
ADD

Targetting Esophageal and Gastric Cancers with Monoclonal Antibodies
pp. 1678-1682(5)
Authors: Norguet, Emmanuelle; Dahan, Laetitia; Seitz, Jean-Francois

Favourites:
ADD

Search for Distinctive Markers in DNT and Cortical Grade II Glioma in Children: Same Clinicopathological and Molecular Entities?
pp. 1683-1692(10)
Authors: Padovani, Laetitia; Colin, Carole; Fernandez, Carla; Maues de Paula, Andre; Mercurio, Sandy; Scavarda, Didier; Frassineti, Frederic; Adelaide, Jose; Loundou, Anderson; Intagliata, Dominique; Bouvier, Corinne; Lena, Gabriel; Birnbaum, Daniel; Girard, Nadine; Figarella-Branger, Dominique

Favourites:
ADD

Anticancer Drugs in Liposomal Nanodevices: A Target Delivery for a Targeted Therapy
pp. 1693-1712(20)
Authors: Urbinati, Giorgia; Marsaud, Veronique; Renoir, Jack-Michel

Favourites:
ADD

Population Pharmacokinetic Analysis of 5-FU and 5-FDHU in Colorectal Cancer Patients: Search for Biomarkers Associated with Gastro-Intestinal Toxicity
pp. 1713-1719(7)
Authors: Woloch, Christian; Di Paolo, Antonello; Marouani, Hafedh; Bocci, Guido; Ciccolini, Joseph; Lacarelle, Bruno; Danesi, Romano; Iliadis, Athanassios

Favourites:
ADD
Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more